Pharmaceutical Peptides

LL-37 (Cathelicidin)

LL-37 is the only cathelicidin-derived antimicrobial peptide found in humans. This 37-amino-acid peptide (beginning with two leucine residues, hence 'LL') is a critical component of the innate immune system, produced by neutrophils, macrophages, and epithelial cells. LL-37 exhibits broad-spectrum antimicrobial activity against bacteria, viruses, and fungi through direct membrane disruption. Beyond its antimicrobial role, LL-37 modulates immune responses including chemotaxis, inflammasome activation, and wound healing. Research interest in LL-37 has surged due to its potential applications in antibiotic-resistant infections and immune modulation. We supply LL-37 in high-purity lyophilized form for pharmaceutical research and antimicrobial development programs.

Technical Specifications

Molecular Weight4493.33 g/mol
Purity≥95% (HPLC)
FormLyophilized powder
Storage-20°C
CAS154947-66-7

Frequently Asked Questions About LL-37 (Cathelicidin)

Human antimicrobial peptide with broad-spectrum antimicrobial activity and immunomodulatory properties for pharmaceutical research.

We supply LL-37 (Cathelicidin) at ≥95% (HPLC) purity. Higher purity grades are available for pharmaceutical applications upon request.

Minimum order quantities for wholesale LL-37 (Cathelicidin) depend on the quantity and purity grade required. Contact our sales team for specific pricing and MOQ information.

LL-37 (Cathelicidin) should be stored at -20°C in a desiccated environment. Proper cold-chain shipping is maintained for all deliveries.

Related Pharmaceutical Peptides

Request Price List